Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

26.77 USD +0.09 (+0.33%)
Streaming Delayed Price Updated: 11:17 AM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bausch Health Companies Inc

< Previous 1 2 3 4 5 6 7 Next >
Bausch Health Releases 2018 Corporate Social Responsibility Report
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today released its second annual Corporate Social Responsibility (CSR) Report. The report showcases the Company's efforts... 
From PR Newswire
Bausch Health To Reduce Debt By Approximately $200 Million Using Cash Flow From Operations
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it will reduce debt by approximately $200 million through the prepayment of senior secured term loans and... 
From PR Newswire
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the Company will participate in three investor conferences. 
From PR Newswire
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-123 Treatment For Acne Vulgaris In Lotion Form
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced that the U.S. Food... 
From PR Newswire
Bausch Health Companies Inc. Announces Second-Quarter 2019 Results And Raises Full-Year Guidance
From PR Newswire
Bausch Health Expands Dermatology Cash-Pay Prescription Program to Walgreens Stores Nationwide
Walgreens and Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced a modification to their existing fulfillment agreement to bring patients lower prices, increased... 
From PR Newswire
Bausch Health Expands Dermatology Cash-Pay Prescription Program to Walgreens Stores Nationwide
Walgreens and Bausch Health bring patients lower prices, increased transparency and greater convenience for dermatology products. 
From Business Wire News Releases
Bausch Health Provides APRISO® Intellectual Property Litigation Update
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") along with its wholly owned subsidiary, Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical... 
From PR Newswire
Bausch Health to Reduce Debt by Additional $100 Million Using Cash Flow from Operations
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it put in notice to pay down an additional $100 million of its senior secured term loans this week, using... 
From PR Newswire
Court Upholds The Validity And Determined Actavis' Infringement Of Patent Protecting RELISTOR® Tablets
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") and Progenics Pharmaceuticals (NASDAQ: PGNX), announced today that the U.S. District Court of New Jersey upheld the... 
From PR Newswire
Bausch + Lomb Announces U.S. Launch Of Ocuvite® Eye Performance Vitamins
Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TXS: BHC), today announced the U.S. launch of Ocuvite® Eye Performance vitamins, a... 
From PR Newswire
Bausch Health Companies Inc. Will Release Second-Quarter 2019 Financial Results On August 6
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter 2019 financial results on Tuesday, Aug. 6, 2019. Bausch Health will host a conference call and live web... 
From PR Newswire
Bausch Health To Reduce Debt By Additional $100 Million Using Cash Generated From Operations
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it put in notice to pay down an additional $100 million of its senior secured term loans this week, using... 
From PR Newswire
Bausch Health Announces U.S. Launch of DUOBRII™ (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis in Adults
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced that DUOBRII™... 
From PR Newswire
Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses Now Available In the United States
Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TXS: BHC), today announced the U.S. launch of Bausch + Lomb ULTRA® Multifocal for... 
From PR Newswire
State Street Global Advisors Announces Impact of Receiving Payment
The SPDR® Exchange Traded Fund (ETF) listed in the table below, announced today that the Fund received a payment as an authorized claimant from a class action settlement related to Salix... 
From Business Wire News Releases
Bausch Health Companies Announces Participation in Upcoming Investor Conferences
Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the Company will participate in two investor conferences in June. 
From PR Newswire
Bausch Health Announces Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior Notes
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health," the "Company" or the "Offeror") announced today the results to date of its pending cash tender offers (collectively, the "Tender Offers,"... 
From PR Newswire
Bausch Health Announces Pricing Of Private Offering Of Senior Notes
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has priced its previously announced offering of $750,000,000 aggregate principal amount of 7.000%... 
From PR Newswire
Bausch Health Announces Launch Of Private Offering Of Senior Notes
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of $750,000,000 aggregate principal amount of senior notes due 2028 (the... 
From PR Newswire
InvestorsObserver releases stock and option data on Apple, Bausch Health, Nike, NVIDIA, and Sally Beauty
InvestorsObserver issues critical PriceWatch Alerts for AAPL, BHC, NKE, NVDA, and SBH. 
From PR Newswire
Glaucoma Treatment and Therapeutics Market Projected to Have Strong Growth Rate Through 2028
Financialnewsmedia.com News Commentary 
From PR Newswire
Glaucoma Treatment and Therapeutics Market Projected To Have Strong Growth Rate Through 2028
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Bausch Health Companies Inc. Announces First-Quarter 2019 Results And Raises Full-Year Guidance
From PR Newswire
Bausch Health Issues Form 8K For 2019 Annual Meeting Of Shareholders Presentation
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced Bausch Health Companies Inc. (the "Company") is providing a presentation (the "2019 Annual Meeting of Shareholders") on... 
From PR Newswire
Bausch + Lomb Announces New Scientific Analyses Featuring Surgical And Pharmaceutical Products Will Be Presented During The Annual Meeting Of The American Society Of Cataract And Refractive Surgery
Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TXS: BHC), today announced that 26 new scientific analyses, including 23 podium... 
From PR Newswire
New Scientific And Clinical Analyses Regarding Bausch + Lomb Surgical And Pharmaceutical Products To Be Presented During The Association For Research In Vision And Ophthalmology Meeting
Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TXS: BHC), today announced that researchers will present the results of nine new... 
From PR Newswire
IIROC Trade Resumption - BHC
From PR Newswire
FDA Approves Bausch Health's DUOBRII™ (Halobetasol Propionate And Tazarotene) Lotion 0.01%/0.045% For Plaque Psoriasis In Adults
First and Only Topical Lotion Combining Halobetasol Propionate and Tazarotene in One Formulation(1) 
From PR Newswire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.